Ethical Profile
Mixed.
Not enough information to create an ethical profile.
SWKH.US | Other financial service activities, except insurance and pension funding activities, n.e.c.
SWK Holdings Corporation is a specialty finance company focused on providing flexible financing solutions to companies in the life science and healthcare sectors. They offer customized debt financing, including term loans, revenue interest financings, and other structured solutions, to support growt...Show More
Ethical Profile
Not enough information to create an ethical profile.
Similar Companies
The provided articles focus exclusively on SWK Holdings Corporation's financial performance, investment portfolio, and loan transactions. While the company operates in the life science and healthcare sectors, none of the articles offer specific, concrete data points regarding the health impact, safety records, accessibility, or other health-related outcomes of the companies SWK Holdings finances.
SWK Holdings Corporation is a specialty finance company that provides debt financing solutions to companies in the life science and healthcare sectors.
No specific data points or mentions of SWKH.US related to any of the 'Fair Pay & Worker Respect' KPIs were found in the provided articles. describes the metrics used in a general evaluation system but explicitly states it contains no specific data for SWKH.US.
No evidence available to assess SWK Holdings Corporation on Fair Trade & Ethical Sourcing.
The company's Code of Ethics and Conduct, applicable to all directors and employees, includes a non-retaliation clause for those reporting suspected violations.
Insufficient evidence to determine a value score for SWK Holdings Corporation regarding Kind to Animals. No articles or relevant information found. A neutral score of 0 is assigned. Materiality Analysis: Company Summary (75-100 words): SWK Holdings Corporation is a principal investment firm focusing on the healthcare sector, including biopharma, medical devices, diagnostics, life science tools, and healthcare services. They typically invest between $5 million and $20 million per transaction. As an investment firm, SWK Holdings does not directly manufacture products or provide services to end consumers; instead, they provide capital to companies operating in the aforementioned sectors. Their headquarters are located in Dallas, Texas. Peer Comparison (50-75 words): As an investment firm, direct peer comparison for "Kind to Animals" is challenging. Other investment firms may have similar indirect impacts based on their portfolio companies. However, the materiality depends on the specific activities of the companies SWK invests in, relative to the animal welfare standards of their respective industries. Materiality Assessment (1-2 clear sentences): SWK Holdings' business model has a neutral relationship with the value "Kind to Animals," with a low level of materiality. The firm's impact is indirect, stemming from the animal welfare practices of its portfolio companies. Detailed Rationale (150-200 words): SWK Holdings is an investment firm, and its direct operations do not involve animal testing, animal agriculture, or the use of animal-derived products. The materiality of "Kind to Animals" is therefore determined by the activities of the companies in which SWK invests. If SWK invests in companies involved in animal testing (e.g., pharmaceutical or medical device companies), factory farming, or the use of animal-derived ingredients, its investments could indirectly contribute to practices that negatively impact animal welfare. Conversely, investments in companies developing animal-free testing methods or promoting ethical sourcing could have a positive impact. Due to the broad range of potential investments within the healthcare sector, it is difficult to assess the overall impact without specific information on SWK's portfolio. The firm's due diligence process could include assessing the animal welfare practices of potential investments, but this is not explicitly stated in its company description. Value Interaction Notes (if applicable, 25-50 words): Investment decisions that prioritize financial returns might conflict with investments that prioritize animal welfare. Balancing these competing priorities could be a challenge. Scoring Boundary Flags (if applicable, 25-50 words): A high positive score would be illogical unless SWK Holdings actively prioritizes investments in companies with strong animal welfare practices and avoids investments in companies with poor practices. A significantly negative score would be inappropriate without evidence of consistent investment in companies with demonstrably harmful animal welfare practices.
SWK Holdings Corporation is a finance company specializing in the global healthcare and life sciences sectors, providing capital solutions and investing in "marketed ethical product cash flow streams."
No specific, quantitative data or concrete facts related to SWK Holdings Corporation's planet-friendly business practices, such as greenhouse gas emissions, renewable energy usage, water consumption, waste diversion, or climate targets, were found in the provided articles. The available information primarily consists of financial data from a Form 10-K
The provided articles do not contain any specific, concrete data points or information regarding SWK Holdings Corporation's performance on any of the KPIs related to 'Respect for Cultures & Communities'. The articles primarily focus on ESG risk ratings, corporate governance, or are promotional/throttled, and explicitly state a lack of relevant data for community engagement, cultural preservation, or local impact metrics.
No evidence available to assess SWK Holdings Corporation on Safe & Smart Tech.
No evidence available to assess SWK Holdings Corporation on Zero Waste & Sustainable Products.
Upload your portfolio and see how all your holdings score across 11 ethical dimensions.
Audit My PortfolioAI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.